Nasal insulin gel as an alternate to parenteral insulin: Formulation, preclinical, and clinical studies

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

The objective of the present study was to formulate insulin gel for intranasal administration and to evaluate with respect to in vitro release studies and hypoglycemic activity in animal model and healthy human volunteers. The insulin gel was formulated using the combination of carbopol and hydroxypropyl methylcellulose as gelling agent. The in vivo efficacy of insulin gel administered intranasally was assessed by measuring the blood glucose levels and serum insulin levels at specified time intervals in rats and humans. The use of bioadhesive nasal gel containing insulin not only promoted the prolonged contact between the drug and the absorptive sites in the nasal cavity but also facilitated direct absorption of medicament through the nasal mucosa. Absorption of the drug through the nasal mucosa was high in the first 0.5 to 1.5 hours of the study with a sharp decline in blood sugar and rise in insulin values corresponding to that decline in blood sugar. This study further demonstrates that administration of insulin intranasally in gel form is a pleasant and painless alternative to injectable insulin.

Original languageEnglish
Article number27
JournalAAPS PharmSciTech
Volume6
Issue number2
DOIs
Publication statusPublished - 30-09-2005

Fingerprint

Nose
clinical trials
insulin
Gels
gels
Insulin
blood glucose
nasal mucosa
Blood Glucose
Nasal Mucosa
gelling agents
intranasal administration
Intranasal Administration
glycemic effect
methylcellulose
nasal cavity
Clinical Studies
Nasal Cavity
Hypoglycemic Agents
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmaceutical Science

Cite this

@article{e7b57efc87f14acbb4889130fe396f32,
title = "Nasal insulin gel as an alternate to parenteral insulin: Formulation, preclinical, and clinical studies",
abstract = "The objective of the present study was to formulate insulin gel for intranasal administration and to evaluate with respect to in vitro release studies and hypoglycemic activity in animal model and healthy human volunteers. The insulin gel was formulated using the combination of carbopol and hydroxypropyl methylcellulose as gelling agent. The in vivo efficacy of insulin gel administered intranasally was assessed by measuring the blood glucose levels and serum insulin levels at specified time intervals in rats and humans. The use of bioadhesive nasal gel containing insulin not only promoted the prolonged contact between the drug and the absorptive sites in the nasal cavity but also facilitated direct absorption of medicament through the nasal mucosa. Absorption of the drug through the nasal mucosa was high in the first 0.5 to 1.5 hours of the study with a sharp decline in blood sugar and rise in insulin values corresponding to that decline in blood sugar. This study further demonstrates that administration of insulin intranasally in gel form is a pleasant and painless alternative to injectable insulin.",
author = "Reshma D'Souza and Srinivas Mutalik and Venkatesh and Sudha Vidyasagar and Nayanabhirama Udupa",
year = "2005",
month = "9",
day = "30",
doi = "10.1208/pt060227",
language = "English",
volume = "6",
journal = "AAPS PharmSciTech",
issn = "1530-9932",
publisher = "American Association of Pharmaceutical Scientists",
number = "2",

}

TY - JOUR

T1 - Nasal insulin gel as an alternate to parenteral insulin

T2 - Formulation, preclinical, and clinical studies

AU - D'Souza, Reshma

AU - Mutalik, Srinivas

AU - Venkatesh,

AU - Vidyasagar, Sudha

AU - Udupa, Nayanabhirama

PY - 2005/9/30

Y1 - 2005/9/30

N2 - The objective of the present study was to formulate insulin gel for intranasal administration and to evaluate with respect to in vitro release studies and hypoglycemic activity in animal model and healthy human volunteers. The insulin gel was formulated using the combination of carbopol and hydroxypropyl methylcellulose as gelling agent. The in vivo efficacy of insulin gel administered intranasally was assessed by measuring the blood glucose levels and serum insulin levels at specified time intervals in rats and humans. The use of bioadhesive nasal gel containing insulin not only promoted the prolonged contact between the drug and the absorptive sites in the nasal cavity but also facilitated direct absorption of medicament through the nasal mucosa. Absorption of the drug through the nasal mucosa was high in the first 0.5 to 1.5 hours of the study with a sharp decline in blood sugar and rise in insulin values corresponding to that decline in blood sugar. This study further demonstrates that administration of insulin intranasally in gel form is a pleasant and painless alternative to injectable insulin.

AB - The objective of the present study was to formulate insulin gel for intranasal administration and to evaluate with respect to in vitro release studies and hypoglycemic activity in animal model and healthy human volunteers. The insulin gel was formulated using the combination of carbopol and hydroxypropyl methylcellulose as gelling agent. The in vivo efficacy of insulin gel administered intranasally was assessed by measuring the blood glucose levels and serum insulin levels at specified time intervals in rats and humans. The use of bioadhesive nasal gel containing insulin not only promoted the prolonged contact between the drug and the absorptive sites in the nasal cavity but also facilitated direct absorption of medicament through the nasal mucosa. Absorption of the drug through the nasal mucosa was high in the first 0.5 to 1.5 hours of the study with a sharp decline in blood sugar and rise in insulin values corresponding to that decline in blood sugar. This study further demonstrates that administration of insulin intranasally in gel form is a pleasant and painless alternative to injectable insulin.

UR - http://www.scopus.com/inward/record.url?scp=27744573524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27744573524&partnerID=8YFLogxK

U2 - 10.1208/pt060227

DO - 10.1208/pt060227

M3 - Article

C2 - 16353976

AN - SCOPUS:27744573524

VL - 6

JO - AAPS PharmSciTech

JF - AAPS PharmSciTech

SN - 1530-9932

IS - 2

M1 - 27

ER -